Partner Sarah Roller Quoted on FDA’s Zero Tolerance Policy for Labeling Allergens
July 26, 2010

In a Food Chemical News article titled “Industry Delves Into FDA Crackdown, Talks Strategy, At IFT Meeting,” partner Sarah Roller was quoted. The article discussed the impact of the Food and Drug Administration’s (FDA) food regulatory presence at the Institute for Food Technologists annual meeting, which included over 115 conference sessions related to food policy changes.

Ms. Roller was a panelist in a discussion regarding the FDA’s zero tolerance policy for labeling allergens. “From a legal standpoint, zero tolerance standards can pose significant liability risks,” said Ms. Roller. Because of unclear regulatory standards, businesses are forced to practice “defensive medicine” to protect themselves against lawsuits, instituting more allergen labeling and announcing recalls that later prove to groundless, Ms. Roller said. Ms. Roller advised clients to implement a food liability prevention program, “a legal HACCP,” as one way to protect themselves.